Reshaping the Bet v 1 fold modulates TH polarization

Journal of Allergy and Clinical Immunology

Volumn 127, Issue 6, 2011, Pages

  Wallner, Michael ^a   Hauser, Michael ^a   Himly, Martin ^a   Zaborsky, Nadja ^a   Mutschlechner, Sonja ^b   Harrer, Andrea ^a   Asam, Claudia ^a   Pichler, Ulrike ^a   Van Ree, Ronald ^c   Briza, Peter ^a   Thalhamer, Josef ^a   Bohle, Barbara ^b   Achatz, Gernot ^a   Ferreira, Fatima ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

allergenicity; antigen uptake; Bet v 1 family; IgE reactivity; lysosomal degradation; Protein remodeling; tree pollen allergens

Indexed keywords

ALUMINUM HYDROXIDE; AMINO ACID; RECOMBINANT ALLERGEN; RECOMBINANT BET V 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIRCH; BIRCH POLLEN; COMPUTER ANALYSIS; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNIZATION; IMMUNOLOGY; MOUSE; MUTATION; NONHUMAN; POLLEN; POLLEN ALLERGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; TH1 CELL; TH2 CELL; WILD TYPE;

EID: 79957815743     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.01.064     Document Type: Article

References (28)

1. Wills-Karp M, Nathan A, Page K, Karp CL. New insights into innate immune mechanisms underlying allergenicity. Mucosal Immunol 2010;3:104-10.
2. Mothes N, Horak F, Valenta R. Transition from a botanical to a molecular classification in tree pollen allergy: implications for diagnosis and therapy. Int Arch Allergy Immunol 2004;135:357-73. (Pubitemid 40082203)
3. Wagner S, Radauer C, Bublin M, Hoffmann-Sommergruber K, Kopp T, Greisenegger EK, et al. Naturally occurring hypoallergenic Bet v 1 isoforms fail to induce IgE responses in individuals with birch pollen allergy. J Allergy Clin Immunol 2008;121:246-52.
4. Zaborsky N, Brunner M, Wallner M, Himly M, Karl T, Schwarzenbacher R, et al. Antigen aggregation decides the fate of the allergic immune response. J Immunol 2010;184:725-35.
5. Smole U, Wagner S, Balazs N, Radauer C, Bublin M, Allmaier G, et al. Bet v 1 and its homologous food allergen Api g 1 stimulate dendritic cells from birch pollenallergic individuals to induce different Th-cell polarization. Allergy 2010;65: 1388-96.
6. van Ree R, Chapman MD, Ferreira F, Vieths S, Bryan D, Cromwell O, et al. The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification. Allergy 2008;63:310-26. (Pubitemid 351224688)
7. Himly M, Nony E, Chabre H, Van Overtvelt L, Neubauer A, van Ree R, et al. Standardization of allergen products, 1: detailed characterization of GMP-produced recombinant Bet v 1.0101 as biological reference preparation. Allergy 2009;64: 1038-45.
8. Oberg KA, Ruysschaert JM, Goormaghtigh E. The optimization of protein secondary structure determination with infrared and circular dichroism spectra. Eur J Biochem 2004;271:2937-48. (Pubitemid 38980278)
9. Vogel L, Luttkopf D, Hatahet L, Haustein D, Vieths S. Development of a functional in vitro assay as a novel tool for the standardization of allergen extracts in the human system. Allergy 2005;60:1021-8. (Pubitemid 40942756)
10. Gamboa PM, Sanz ML, Caballero MR, Antepara I, Urrutia I, Jauregui I, et al. Use of CD63 expression as a marker of in vitro basophil activation and leukotriene determination in metamizol allergic patients. Allergy 2003;58:312-7. (Pubitemid 36566749)
11. Wallner M, Stocklinger A, Thalhamer T, Bohle B, Vogel L, Briza P, et al. Allergy multivaccines created by DNA shuffling of tree pollen allergens. J Allergy Clin Immunol 2007;120:374-80. (Pubitemid 47102390)
12. Bauer R, Scheiblhofer S, Kern K, Gruber C, Stepanoska T, Thalhamer T, et al. Generation of hypoallergenic DNA vaccines by forced ubiquitination: preventive and therapeutic effects in a mouse model of allergy. J Allergy Clin Immunol 2006;118:269-76. (Pubitemid 43946474)
13. Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 2005;307: 1630-4. (Pubitemid 40354746)
14. Thalhamer T, Dobias H, Stepanoska T, Proll M, Stutz H, Dissertori O, et al. Designing hypoallergenic derivatives for allergy treatment by means of in silico mutation and screening. J Allergy Clin Immunol 2010;125:926-34, e10.
15. Son DY, Scheurer S, Hoffmann A, Haustein D, Vieths S. Pollen-related food allergy: cloning and immunological analysis of isoforms and mutants of Mal d 1, the major apple allergen, and Bet v 1, the major birch pollen allergen. Eur J Nutr 1999;38:201-15. (Pubitemid 29454998)
16. Scheurer S, Son DY, Boehm M, Karamloo F, Franke S, Hoffmann A, et al. Cross-reactivity and epitope analysis of Pru a 1, the major cherry allergen. Mol Immunol 1999;36:155-67. (Pubitemid 29281842)
17. Neudecker P, Lehmann K, Nerkamp J, Haase T, Wangorsch A, Fotisch K, et al. Mutational epitope analysis of Pru av 1 and Api g 1, the major allergens of cherry (Prunus avium) and celery (Apium graveolens): correlating IgE reactivity with three-dimensional structure. Biochem J 2003;376:97-107. (Pubitemid 37487206)
18. Reese G, Ballmer-Weber BK, Wangorsch A, Randow S, Vieths S. Allergenicity and antigenicity of wild-type and mutant, monomeric, and dimeric carrot major allergen Dau c 1: destruction of conformation, not oligomerization, is the roadmap to save allergen vaccines. J Allergy Clin Immunol 2007;119:944-51. (Pubitemid 46527808)
19. Mogensen JE, Wimmer R, Larsen JN, Spangfort MD, Otzen DE. The major birch allergen, Bet v 1, shows affinity for a broad spectrum of physiological ligands. J Biol Chem 2002;277:23684-92.
20. Ferreira F, Ebner C, Kramer B, Casari G, Briza P, Kungl AJ, et al. Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy. FASEB J 1998;12:231-42. (Pubitemid 28080193)
21. Egger M, Hauser M, Himly M, Wopfner N, Wallner M, Ferreira F. Development of recombinant allergens for diagnosis and therapy. Front Biosci (Elite Ed) 2009;1: 77-90.
22. Mutschlechner S, Egger M, Briza P, Wallner M, Lackner P, Karle A, et al. Naturally processed T cell-activating peptides of the major birch pollen allergen. J Allergy Clin Immunol 2010;125:711-8, 8 e1-8 e2.
23. Swoboda I, Jilek A, Ferreira F, Engel E, Hoffmann-Sommergruber K, Scheiner O, et al. Isoforms of Bet v 1, the major birch pollen allergen, analyzed by liquid chromatography, mass spectrometry, and cDNA cloning. J Biol Chem 1995;270: 2607-13.
24. Ferreira F, Hirtenlehner K, Jilek A, Godnik-Cvar J, Breiteneder H, Grimm R, et al. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy. J Exp Med 1996;183:599-609.
25. Wallner M, Himly M, Neubauer A, Erler A, Hauser M, Asam C, et al. The influence of recombinant production on the immunologic behavior of birch pollen isoallergens. PLoS One 2009;4:e8457.
26. Constant S, Pfeiffer C, Woodard A, Pasqualini T, Bottomly K. Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J Exp Med 1995;182:1591-6.
27. Martonen TB, Orourke MK. Deposition patterns of ragweed pollen in the human respiratory-tract. Grana 1991;30:82-6.
28. Runswick S, Mitchell T, Davies P, Robinson C, Garrod DR. Pollen proteolytic enzymes degrade tight junctions. Respirology 2007;12:834-42. (Pubitemid 350045730)